SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : GenVec
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Gary Mohilner7/22/2008 10:04:03 PM
   of 19
 
Anyone know why the stock symbol doesn't appear on this site or the other one that comes up under GenVec.

I'd certainly like to see an active board here. I believe that both share price and activity in the stock will grow as we approach Fall and Winter, especially if we haven't taken a peek before then. I was asked by someone on Investor's Village how I estimated the efficacy increase with time after posting that I believe in June the drug should already be at least 20% better then the SOC. My answer went something like this.

Each succeeding month should add roughly 10 to 15% in lifespan, so if we're at 20% at the end of June by the end of December we'd be up by 80% with the 10% figure and 110% with the 15% one. In months we're talking about roughly 19 to 23 months on the drug if 11 months remains the SOC figure. I think this equates closely to what the company's been saying.

Gary
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News